Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB

被引：3

作者：

Oehadian, A. ^{[1
,2
]}

Bastos, M. L. ^{[3
,4
]}

Centis, R. ^{[5
]}

D'Ambrosio, L. ^{[6
]}

Migliorie, G. B. ^{[5
]}

Santoso, P. ^{[7
]}

Ruslami, R. ^{[8
]}

Menzies, D. ^{[9
,10
]}

机构：

[1] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Fac Med, Hematol & Oncol Med Div,Dept Internal Med, Bandung, Indonesia

[2] Univ Padjadjaran, Doctoral Study Program, Fac Med, Bandung, West Java, Indonesia

[3] McGill Univ, Res Inst, McGill Int TB Ctr, Montreal Ctr Hlth,Hlth Ctr, Montreal, PQ, Canada

[4] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, Brazil

[5] Ist Clin Sci Maugeri IRCCS, Serv Epidemiol Clin Malattie Resp, Tradate, Italy

[6] Publ Hlth Consulting Grp, Lugano, Switzerland

[7] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Dept Internal Med, Div Respirol & Crit Care,Fac Med, Bandung, Indonesia

[8] Padjadjaran State Univ, Dr Hasan Sadikin Gen Hosp, Dept Biomed Sci, Div Pharmacol, Bandung, Indonesia

[9] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, 5252 Maisonneuve West,Room 3D-58, Montreal, PQ H4A 3S5, Canada

[10] McGill Int TB Ctr, 5252 Maisonneuve West,Room 3D-58, Montreal, PQ H4A 3S5, Canada

来源：

PULMONOLOGY | 2024年 / 30卷 / 02期

关键词：

MULTIDRUG-RESISTANT TUBERCULOSIS; TOLERABILITY;

D O I：

10.1016/j.pulmoe.2023.09.003

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：184 / 187

页数：4

共 7 条

[1] Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study [J].

Bolhuis, Mathieu S. ;

Tiberi, Simon ;

Sotgiu, Giovanni ;

De Lorenzo, Saverio ;

Kosterink, Jos G. W. ;

van der Werf', Tjip S. ;

Miglioris, Giovanni Battista ;

Alffenaar, Jan-Willem C. .

EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) :1205-1207

[2] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort [J].

Koirala, S. ;

Borisov, S. ;

Danila, E. ;

Mariandyshev, A. ;

Shrestha, B. ;

Lukhele, N. ;

Dalcolmo, M. ;

Shakya, S. R. ;

Miliauskas, S. ;

Kuksa, L. ;

Manga, S. ;

Aleksa, A. ;

Denholm, J. T. ;

Khadka, H. B. ;

Skrahina, A. ;

Diktanas, S. ;

Ferrarese, M. ;

Bruchfeld, J. ;

Koleva, A. ;

Piubello, A. ;

Koirala, G. S. ;

Udwadia, Z. F. ;

Palmero, D. J. ;

Munoz-Torrico, M. ;

Gc, R. ;

Gualano, G. ;

Grecu, V., I ;

Motta, I ;

Papavasileiou, A. ;

Li, Y. ;

Hoefsloot, W. ;

Kunst, H. ;

Mazza-Stalder, J. ;

Payen, M-C ;

Akkerman, O. W. ;

Bernal, E. ;

Manfrin, V ;

Matteelli, A. ;

Hamdan, H. Mustafa ;

Marcos, M. Nieto ;

Cadinanos Loidi, J. ;

Cebrian Gallardo, J. J. ;

Duarte, R. ;

Escobar Salinas, N. ;

Gomez Rosso, R. ;

Laniado-Laborin, R. ;

Martinez Robles, E. ;

Quiros Fernandez, S. ;

Rendon, A. ;

Solovic, I .

PULMONOLOGY, 2021, 27 (05) :403-412

[3] Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study [J].

Letswee, Gotlhe ;

Kamau, Hellen ;

Gaida, Razia ;

Truter, Ilse .

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2019, 27 (06) :575-577

[4] A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis [J].

Migliori, G. B. ;

Eker, B. ;

Richardson, M. D. ;

Sotgiu, G. ;

Zellweger, J. -P. ;

Skrahina, A. ;

Ortmann, J. ;

Girardi, E. ;

Hoffmann, H. ;

Besozzi, G. ;

Bevilacqua, N. ;

Kirsten, D. ;

Centis, R. ;

Lange, C. .

EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (02) :387-393

[5]

Pratama Novan Yusuf Indra, 2021, Journal of Basic and Clinical Physiology and Pharmacology, V32, P777, DOI 10.1515/jbcpp-2020-0468

[6] Managing multidrug-resistant tuberculosis in children: review of recent developments [J].

Schaaf, H. Simon ;

Garcia-Prats, Anthony J. ;

Hesseling, Anneke C. ;

Seddon, James A. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2014, 27 (03) :211-219

[7]

Zhang P, 2022, China Infect Drug Resist, P2617

← 1 →